84 93 102 131 133 133 133 134 |Semi-Annual Report September 30, 2023 3 President's Letter (Unaudited) September 30, 2023 Dear DoubleLine Funds Shareholder, On behalf of the DoubleLine Funds, I am pleased to deliver the Semi-Annual Report for the six-month period ended September 30, 2023...
February 29, 2024 Semi-Annual Report DBX ETF Trust Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF (EMCR) Xtrackers MSCI EAFE ESG Leaders Equity ETF (EASG) Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF (EMSG) Xtrackers MSCI USA Climate Action Equity ETF (USCA)...
Astra Agro Lestari Tbk PT Astra International Tbk PT AstraZeneca PLC Astro Malaysia Holdings Bhd Asustek Computer Inc ASX Ltd AT&T Inc Atacadao Distribuicao Comercio e Industria Ltda Atco Ltd Atento SA Athene Holding Ltd 177,186 452,069 1,331,247 259,065 627,944 2,755,143 289,903 1,042...
(PERUS IDR500* P.T. ASTRA INTL IDR50* PT BANK NEGARA IND LKD SHS(IDR7500 & IDR375)* Total Indonesia Macau SANDS CHINA LTD USD0.01 REG'S'* Total Macau Malaysia CIMB GROUP HOLDINGS BHD MYR1* Total Malaysia Philippines LT GROUP INC PHP1* PHILIPPINE SEVEN PHP1* Total Philippines South ...
(a) + 6.75% 09/19/25 418,372 Astra Acquisition Corp., First Lien ‐ 3M SOFR 188,028 Initial Term Loan + 5.25% 10/22/28 122,610 Astra Acquisition Corp., Second Lien...
Asset Management UBS Funds Semi-Annual Report 2023 Unaudited semi-annual report as of 30 November 2023 Investment Company under Luxembourg Law (SICAV) R.C.S. Luxembourg N° B 56 386 UBS (Lux) Equity SICAV UBS (Lux) Equity SICAV – Active Climate Aware (USD) UBS (Lux) Equity SICAV – ...
Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for...
MedImmune/AstraZeneca. Data on file. 2. Ibrahim R, Stewart R, Shalabi A: PD-L1 blockade for cancer treatment: MEDI4736. Semin Oncol 2015, 42:474–483. 3. Rizvi NA, Brahmer JR, Ou SHI, Segal NH, Khleif S, Hwu WJ, et al: Safety and clinical activity of MEDI4736, an anti-...
Kevin Winthrop Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer, AbbVie, UCB, Eli Lilly, Galapagos, GSK, Roche, Gilead, BMS, Regeneron, Sanofi, AstraZeneca, Novartis, Moderna. Kevin Winthrop has received personal compensati...
J.Vestbo has received honoraria from AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK and Novartis. Funding: The abstract has been funded by Chiesi Farmaceutici S.p.A. Corresponding author: Mario Scuri. Email: m.scuri@chiesi.com discussing patients' ability and confidence to self-manage asthma,...